New Insights into Adjuvant Therapy in Renal Cell Carcinoma: Is the Chapter of VEGF Inhibitors Definitely Closed?

被引：6
|
作者：
Peyraud, Florent [1 ]
Larroquette, Mathieu [1 ]
Ravaud, Alain [1 ,2 ]
Gross-Goupil, Marine [1 ]
机构：
[1] Bordeaux Univ Hosp, Dept Med Oncol, Bordeaux, France
[2] Bordeaux Univ, Bordeaux, France
来源：
EUROPEAN UROLOGY | 2021年 / 80卷 / 03期
关键词：
HIGH-RISK; SUNITINIB; PLACEBO;
D O I：
10.1016/j.eururo.2021.03.011
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：269 / 274
页数：6
相关论文
共 50 条
  • [21] Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma
    Kuusk, Teele
    Bex, Axel
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (05) : 907 - 920
  • [22] High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors?
    Fallara, Giuseppe
    Bandini, Marco
    Larcher, Alessandro
    Pederzoli, Filippo
    Karakiewicz, Pierre
    Tian, Zhe
    Briganti, Alberto
    Necchi, Andrea
    Salonia, Andrea
    Bertini, Roberto
    Montorsi, Francesco
    Bex, Axel
    Capitanio, Umberto
    CURRENT PROBLEMS IN CANCER, 2021, 45 (06)
  • [23] Immunomodulatory Roles of VEGF Pathway Inhibitors in Renal Cell Carcinoma
    Hirsch, Laure
    Flippot, Ronan
    Escudier, Bernard
    Albiges, Laurence
    DRUGS, 2020, 80 (12) : 1169 - 1181
  • [24] Emerging oral VEGF inhibitors for the treatment of renal cell carcinoma
    Stitzlein, Lea
    Rao, P. S. S.
    Dudley, Richard
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (02) : 121 - 130
  • [25] Immunomodulatory Roles of VEGF Pathway Inhibitors in Renal Cell Carcinoma
    Laure Hirsch
    Ronan Flippot
    Bernard Escudier
    Laurence Albiges
    Drugs, 2020, 80 : 1169 - 1181
  • [26] New adjuvant therapy for renal cell carcinoma also effective in the long term
    Franke, Katharina
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (13) : 754 - 754
  • [27] Safety and Efficacy of Radiation Therapy Concurrent With VEGF and mTOR Inhibitors in Metastatic Renal Cell Carcinoma
    Dandapani, S. V.
    Kazarian, A.
    Hsu, J.
    Vora, N. L.
    Vora, L.
    Liu, A.
    Pal, S. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S150 - S150
  • [28] Adjuvant therapy in renal-cell carcinoma: New drugs, old problems
    Portugal, Gaspar F.
    Silva, A. B.
    Mota, R. L.
    Lopes, F. A.
    Monteiro, L. A.
    EUROPEAN UROLOGY, 2023, 83 : S670 - S670
  • [29] Adjuvant therapy in renal cell carcinoma: Where are we?
    Eisen, Tim
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (07) : 492 - 498
  • [30] Adjuvant Therapy for Renal Cell Carcinoma: Hype or Hope?
    Cosso, Federica
    Roviello, Giandomenico
    Nesi, Gabriella
    Shabani, Sonia
    Spatafora, Pietro
    Villari, Donata
    Catalano, Martina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
12345